These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6440153)

  • 1. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
    Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
    Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
    Maguire ED; Wallis RB
    Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
    Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR
    Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
    O'Keefe EH; Liu EC; Greenberg R; Ogletree ML
    Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors: a comparison of RIA and GC/MS determinations.
    Weber C; Beetens JR; Van de Wiele R; Höller M; De Clerck F
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):7-15. PubMed ID: 1773000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
    Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
    Pedersen AK; Watson ML; FitzGerald GA
    Thromb Res; 1984 Jan; 33(1):99-103. PubMed ID: 6546456
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
    Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do prostacyclin and thromboxane play a role in endotoxic shock?
    Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
    Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis?
    Cerletti C; Chiabrando C; Fanelli R; de Gaetano G
    Lancet; 1984 Apr; 1(8383):967-8. PubMed ID: 6143907
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of dazoxiben on the metabolism of arachidonic acid in isolated porcine basilar arteries].
    Rui YC; Sun DX; Lin AY
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):261-4. PubMed ID: 2128432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 6-keto-PGF1 alpha, TXB2, PGF2 alpha, PGE2, PGD2 in human blood: a comparison of RIA and GC-NICI-MS.
    Weber C; Beetens J; van de Wiele R; Beile A; Lohkamp R; de Clerck F; Höller M
    Prog Clin Biol Res; 1989; 301():113-7. PubMed ID: 2798442
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon.
    Luderer JR; Nicholas GG; Neumyer MM; Riley DL; Vary JE; Garcia G; Schneck DW
    Clin Pharmacol Ther; 1984 Jul; 36(1):105-15. PubMed ID: 6428793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
    Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
    J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.